09.02.15
Pessac, France-based Hyprevention has earned the CE mark for the Y-Strut device, an implantable medical device designed to prevent hip fracture. The company is ready for commercialization in Europe.
Y-Strut is indicated to prevent fractures of the proximal femur. It is intended to be used in two clinical indications: Traumatology, for contralateral percutaneous internal fixation of the proximal femur in patients with a low energy pertrochanteric fracture on the first side; and oncology, for percutaneous internal fixation for impending pathological fracture of proximal femur. In the latter example, Y-Strut is required to be ultima ratio, or an act of last resort.
Y-Strut is implanted via a minimally invasive procedure conducted by an orthopedic surgeion or an interventional radiologist. According to the company, 14 patients already successfully benefited from Y-Strut technology in the clinical trials jointly conducted at the University Hospital of Bordeaux, the Gustave Roussy Institute in Paris and at the University Hospital Brugmann in Brussels.
Hyprevention makes implantable medical devices to targeted to unmet clinical needs.
Y-Strut is indicated to prevent fractures of the proximal femur. It is intended to be used in two clinical indications: Traumatology, for contralateral percutaneous internal fixation of the proximal femur in patients with a low energy pertrochanteric fracture on the first side; and oncology, for percutaneous internal fixation for impending pathological fracture of proximal femur. In the latter example, Y-Strut is required to be ultima ratio, or an act of last resort.
Y-Strut is implanted via a minimally invasive procedure conducted by an orthopedic surgeion or an interventional radiologist. According to the company, 14 patients already successfully benefited from Y-Strut technology in the clinical trials jointly conducted at the University Hospital of Bordeaux, the Gustave Roussy Institute in Paris and at the University Hospital Brugmann in Brussels.
Hyprevention makes implantable medical devices to targeted to unmet clinical needs.